Related Experiment Video

Updated: Aug 16, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and

Christopher B Manning1, Andrew B Cummins, Michael W Jung

  • 1Department of Pathology, University of Vermont, Burlington, Vermont 05405, USA.

Cancer Research
|August 3, 2002
PubMed

Insights

Epidermal Growth Factor Receptor (EGFR) drives asbestos-induced lung cancer by promoting cell proliferation and proto-oncogene expression. Inhibiting EGFR phosphorylation may offer new strategies for preventing and treating asbestos-related lung diseases.

Area of Science:

  • Environmental Health
  • Oncology
  • Molecular Biology

Background:

  • Asbestos exposure is a known cause of lung cancer and other diseases.
  • The precise mechanisms by which asbestos initiates lung cancer, particularly epithelial cell hyperplasia, remain unclear.
  • Understanding these mechanisms is crucial for developing effective preventive and therapeutic strategies.

Purpose of the Study:

  • To investigate the role of Epidermal Growth Factor Receptor (EGFR) in asbestos-induced lung epithelial cell proliferation and proto-oncogene expression.
  • To determine if modulating EGFR activity can prevent asbestos-related lung cancer initiation.
  • To elucidate the signaling pathways involved in asbestos carcinogenicity.

Main Methods:

  • Utilized genetically engineered mice expressing a dominant-negative mutant EGFR under the lung surfactant protein-C promoter.
  • Administered asbestos via inhalation to both mutant EGFR-expressing mice and control littermates.
  • Analyzed pulmonary epithelial cell proliferation, inflammation markers, and expression of early response proto-oncogenes (e.g., c-jun, c-fos) using quantitative reverse transcriptase-PCR and laser capture microdissection.

Main Results:

  • Mice with dominant-negative EGFR exhibited reduced pulmonary epithelial cell proliferation following asbestos exposure, without changes in inflammation.
  • Asbestos-inhalation did not lead to early, elevated expression of proto-oncogenes (fos/jun) in mutant EGFR-expressing mice compared to controls.
  • Quantitative analysis confirmed increased c-jun and c-fos expression in asbestos-exposed bronchiolar epithelial cells of control mice, but not in mutant EGFR mice.

Conclusions:

  • Epidermal Growth Factor Receptor (EGFR) plays a critical role in mediating asbestos-induced proto-oncogene expression and epithelial cell proliferation.
  • EGFR signaling is a key driver of lung cancer initiation following asbestos exposure.
  • Targeting EGFR phosphorylation presents a potential therapeutic and preventive approach for lung cancers and mesothelioma caused by asbestos.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.